Publications by authors named "Howard Gross"

Claim this Profile
W
Walking dose associated with lower cancer-related fatigue among patients with breast cancer.
Lindsey J Mattick, Chin-Shang Li, Po-Ju Lin, Luke J Peppone, Allison Magnuson, Howard Gross

J Natl Cancer Inst· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Southwest Oncology Group S0826: A phase 2 trial of SCH 727965 (NSC 727135, dinaciclib) in patients with stage IV melanoma.
Christopher D Lao, James Moon, Vincent T Ma, John P Fruehauf, Lawrence E Flaherty, Howard Gross

Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Correlation of Magnetic Resonance Tumor Regression Grade With Pathologic Outcomes in Total Neoadjuvant Therapy for Rectal Adenocarcinoma.
William A Hall, Jiahe Li, Y Nancy You, Marc J Gollub, Joseph R Grajo, Howard M Gross

J Clin Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association between cancer-related fatigue and diabetes from pre-chemotherapy to 6 months post-chemotherapy.
Amber S Kleckner, Ian R Kleckner, Eva Culakova, Michelle Shayne, Elizabeth K Belcher, Howard Gross

Support Care Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidance for the Clinical Management of Impacted Maxillary Canines.
Miguel Hirschhaut, Nelson Leon, Howard Gross, Carlos Flores-Mir

Compend Contin Educ Dent· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of topical agents for radiation dermatitis and pain: a randomized clinical trial.
Julie Ryan Wolf, Jennifer S Gewandter, Javier Bautista, Charles E Heckler, Jon Strasser, Howard Gross

Support Care Cancer· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2.
Patricia A Ganz, Edward H Romond, Reena S Cecchini, Priya Rastogi, Charles E Geyer, Howard M Gross

J Clin Oncol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect on Surgical Complications of Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer: NRG Oncology/NSABP Protocol B-40.
Harry D Bear, Gong Tang, Priya Rastogi, Charles E Geyer, Christine K Zoon, Howard M Gross

Ann Surg Oncol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5.
John W Smith, Marc E Buyse, Priya Rastogi, Charles E Geyer, Samuel A Jacobs, Howard M Gross

Clin Breast Cancer· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modafinil Moderates the Relationship Between Cancer-Related Fatigue and Depression in 541 Patients Receiving Chemotherapy.
Claire C Conley, Charles S Kamen, Charles E Heckler, Michelle C Janelsins, Gary R Morrow, Howard Gross

J Clin Psychopharmacol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
Richard G Margolese, Reena S Cecchini, Thomas B Julian, Patricia A Ganz, Joseph P Costantino, Howard M Gross

Lancet· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
Patricia A Ganz, Reena S Cecchini, Thomas B Julian, Richard G Margolese, Joseph P Costantino, Howard M Gross

Lancet· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial.
Harry D Bear, Gong Tang, Priya Rastogi, Charles E Geyer, Qing Liu, Howard M Gross

Lancet Oncol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase 2 study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma : a North Central Cancer Treatment Group study, N0775.
Lisa A Kottschade, Vera J Suman, Domingo G Perez, Robert R McWilliams, Judith S Kaur, Howard M Gross

Cancer· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epidermal growth factor receptor 2-positive breast cancer.
Edward H Romond, Jong-Hyeon Jeong, Priya Rastogi, Sandra M Swain, Charles E Geyer, Howard M Gross

J Clin Oncol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cediranib (AZD2171) in patients with advanced hepatocellular carcinoma: a phase II North Central Cancer Treatment Group Clinical Trial.
Steven Robert Alberts, Tom R Fitch, George P Kim, Bruce W Morlan, Shaker R Dakhil, Howard M Gross

Am J Clin Oncol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exercise and Cancer Treatment Symptoms in 408 Newly Diagnosed Older Cancer Patients.
Lisa K Sprod, Supriya G Mohile, Wendy Demark-Wahnefried, Michelle C Janelsins, Luke J Peppone, Howard Gross

J Geriatr Oncol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study.
Bret B Friday, S Keith Anderson, Jan Buckner, Chunrong Yu, Caterina Giannini, Howard Gross

Neuro Oncol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab added to neoadjuvant chemotherapy for breast cancer.
Harry D Bear, Gong Tang, Priya Rastogi, Charles E Geyer, André Robidoux, Howard M Gross

N Engl J Med· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylactic tetracycline does not diminish the severity of epidermal growth factor receptor (EGFR) inhibitor-induced rash: results from the North Central Cancer Treatment Group (Supplementary N03CB).
Aminah Jatoi, Shaker R Dakhil, Jeff A Sloan, John W Kugler, Kendrith M Rowland, Howard M Gross

Support Care Cancer· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase II trial evaluating two paclitaxel and cisplatin-containing chemoradiation regimens as adjuvant therapy in resected gastric cancer (RTOG-0114).
Gary K Schwartz, Kathryn Winter, Bruce D Minsky, Christopher Crane, P John Thomson, Howard Gross

J Clin Oncol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sinus bone augmentation: a review of the common techniques.
Fred F Farhat, Bassam Kinaia, Howard B Gross

Compend Contin Educ Dent· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes: results of a placebo-controlled trial from the North Central Cancer Treatment Group (N03CB).
Aminah Jatoi, Kendrith Rowland, Jeff A Sloan, Howard M Gross, Paul A Fishkin

Cancer· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3.
Ravi D Rao, Patrick J Flynn, Jeff A Sloan, Gilbert Y Wong, Paul Novotny, Howard M Gross

Cancer· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bisphosphonate-induced osteonecrosis: dental considerations.
Howard B Gross

Compend Contin Educ Dent· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis